CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia
- 1 January 2002
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 16 (1) , 30-35
- https://doi.org/10.1038/sj.leu.2402339
Abstract
Leukemia is one of the leading journals in hematology and oncology. It is published monthly and covers all aspects of the research and treatment of leukemia and allied diseases. Studies of normal hemopoiesis are covered because of their comparative relevance.Keywords
This publication has 15 references indexed in Scilit:
- CD38 expression is a poor predictor for VH gene mutational status and prognosis in chronic lymphocytic leukemiaBlood, 2001
- Genomic Aberrations and Survival in Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 2000
- Fludarabine Compared with Chlorambucil as Primary Therapy for Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 2000
- Immunoglobulin V genes and CD38 expression in CLLBlood, 2000
- CD38/CD31, a Receptor/Ligand System Ruling Adhesion and Signaling in Human LeukocytesPublished by S. Karger AG ,2000
- Unmutated Ig VH Genes Are Associated With a More Aggressive Form of Chronic Lymphocytic LeukemiaBlood, 1999
- Ig V Gene Mutation Status and CD38 Expression As Novel Prognostic Indicators in Chronic Lymphocytic LeukemiaBlood, 1999
- Ligation of CD38 suppresses human B lymphopoiesis.The Journal of Experimental Medicine, 1995
- A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysisCancer, 1981
- Clinical staging of chronic lymphocytic leukemiaBlood, 1975